FA Renal Drugs Flashcards
Mannitol drug type
osmotic diuretic
Mannitol MOA
- increases tubular fluid osmolarity (plasma osmotic pressure) in PCT
- increases urine flow
- decreases intracranial/intraocular pressure
Mannitol Clinical Use
- Drug overdose
- Elevated ICP/IOP
Mannitol Toxicity
- Excessive plasma volume expansion
- Pulmonary congestion/edema
- Dehydration
Mannitol C/I
- Anuria
- Heart failure
Acetazolamide drug type
Carbonic anhydrase inhibitor
Acetazolamide MOA
- Inhibits carbonic anhydrase in brush border and intracellularly in PCT
- No H+ produced → No Na+/H+ exchg → Na+ stays in lumen
- Self-limited NaHCO3 diuresis
- Decrease in total body HCO3- stores
- Alkalinizes urine
Carbonic Anhydrase does what?
- Catalyzes CO2 + H2O → H2CO3
- H2CO3 spontaneously decomposes to HCO3- + H+
- Required for Na+/H+ exchg in PCT, NaHCO3 reabsorption from PCT, and H+ secretion in collecting duct
Acetazolamide Clinical Use
- Glaucoma (reduce aq humor production)
- Metabolic alkalosis
- Altitude sickness
- Pseudotumor cerebri
Acetazolamide Toxicity
- HypERchloremic metabolic acidosis [ACIDazolamide]
- Increased Cl- reabsorption to compensate for decreased bicarb reabsorption
- Acidification of CSF → Paresthesias, other CNS effects
- NH3 toxicity
- Sulfa allergy
- Blood cell deficiencies
Sulfa Diuretics
FAT:
- Furosemide
- Acetazolamide
- Thiazides
Mannitol location of action
PCT
Acetazolamide location of action
PCT
Loop Diuretic Drugs
- Furosemide
- Bumetanide
- Torsemide
- Ethacrynic Acid
Loop Diuretic location of action
Thick Ascending LOH
Loop Diuretic drug type
Sulfonamide (except Ethacrynic Acid)
Loop Diuretic MOA
- Inhibits Na+/K+/2Cl- transporter (out of lumen)
- Abolishes hypertonicity of medulla
- Prevents concentration of urine
- Stim PGE release → afferent arteriole dilation
- Inhibited by NSAIDs
NSAIDs inhibit which diuretics?
Loop diuretics (PGE)
Loop Diuretics increase excretion of which ions?
- Na+
- K+
- Cl-
- Ca2+
- Mg2+
Loop Diuretics clinical use
- Edematous states (HF, cirrhosis, nephrotic synd, pulm edema)
- HTN
- Hypercalcemia
Loop Diuretics Toxicity
OHH DANG!
- Ototoxicity (worsened by aminoglycosides)
- HypOkalemia
- HypOcalcemia
- Dehydration
- Allergy (sulfa)
- Nephritis (interstitial)
- Gout (hyperuricemia)
Preferred diuretics in pts w/renal impairment?
Loop Diuretics
Acetazolamide increases excretion of which ions?
HCO3-
Only non-sulfa Loop Diuretic
Ethacrynic Acid
Diuretic used in pts w/sulfa allergy
Ethacrynic Acid
Ethacrynic Acid drug type
Phenoxyacetic acid derivative
Thiazide Diuretic drugs
- Hydrochlorothiazide
- Chlorthalidone
Thiazide Diuretic location of action
Early DCT
Thiazide Diuretic MOA
- Inhibit NaCl reabsorption in early DCT
- Decrease diluting capacity of nephron
- Decrease Ca2+ excretion (PTH effect)
Thiazide Diuretic Clinical Use
- HTN
- HF
- Edema
- Idiopathic hypERcalciuria
- Nephrogenic diabetes insipidus
- helps concentrate urine
- Osteoporosis
- Calcium stones
Thiazide Diuretic Toxicity
- HypOkalemic Metabolic Alkalosis
- HypOnatremia
- Hyper-GLUC:
- Glycemia
- Lipidemia
- Uricemia
- Calcemia
- Sulfa allergy
Potassium-Sparing Diuretic Drugs
Competitive Aldosterone Receptor Antagonists:
- Spironolactone
- Eplerenone
Sodium Channel Blockers:
- Amiloride
- Triamterene
Competitive Aldosterone Receptor Antagonist Potassium-Sparing Diuretics
- Spironolactone
- Eplerenone
Sodium Channel Blocker Potassium-Sparing Diuretics
- Amiloride
- Triamterene
Amiloride/Triamterene MOA
Block sodium channels in cortical collecting tubule
Spironolactone/Eplerenone MOA
Competitive aldosterone antagonist in cortical collecting tubule
Potassium-Sparing Diuretic location of action
cortical collecting tubule
Spironolactone Clinical Use
- Primary HypERaldosteronism
- Conn’s Synd
- Waterhouse-Friedrichsen Synd
- Polycystic ovary disease
- Hirsutism
- K+ depletion
- HF
Amiloride Clinical Use
- Primary HypERaldosteronism
- HypOkalemia / K+ depletion
- CHF
Potassium-Sparing Diuretic Toxicity
- HypERkalemia → QT interval elongation → arrhythmia
- Endocrine effects → gynecomastia, antiandrogen effects (spironolactone)
ADH Antagonist MOA
- Block ADH at V2 receptor → block insertion of add’l aquaporin channels in collecting tubule
- Facilitate water excretion w/o electrolyte loss
Aquaretic Drug Type
ADH Antagonists
Aquaretic Drugs
- Conivaptan
- Tolvaptan
- Lithium
- Demeclocycline
Aquaretic Drug Clinical Use
- SIADH
- Nephrogenic diabetes insipidus
- Euvolemic/hypERvolemic hypOnatremia
Aquaretic Drug Toxicity
- Photosensitivity, abnormalities of bone and teeth (demeclocycline)
- Nephrogenic DI (demeclocycline & lithium)
Aquaretic Drug C/I
Extensively metabolized by CYP3A4 → do not give w/3A4 inhibitors
- Can increase serum levels of midazolam, simvastatin, other drugs metabolized by 3A4
ADH/Desmopressin MOA
- Activate V2 receptors
- Insert aquaporin channels to facilitate water reabsorption from collecting tubule
- Reduce urine volume
- Increase urine concentration
Desmopressin Clinical Use
- Central diabetes insipidus (intranasal)
- Hemophilia A/B/C
- von Willebrand Disease
- releases vWF stored in endothelium
- Bedwetting (oral)
Rx Central Diabetes Insipidus?
Desmopressin
Rx Nephrogenic Diabetes Insipidus?
- hydrochlorothiazide
- indomethacin
- amiloride
Rx SIADH?
- fluid restriction
- IV hypertonic saline
- conivaptan
- tolvaptan
- demeclocycline
ACE Inhibitor Drugs
- Captopril
- enalapril
- lisinopril
- ramipril
ACE Inhibitor MOA
- Inhibit ACE → decrease AT II → prevent efferent arteriole constriction → decrease GFR
- Loss of feedback inhibition → Renin levels decrease
- Also prevents inactivation of bradykinin, a potent vasodilator
ACE Inhibitor Clinical Use
- HTN
- HF
- Prevention of unfavorable heart remodeling from chronic HTN
- Proteinuria
- Diabetic nephropathy
- decreases intraglomerular pressure → slows GBM thickening
ACE Inhibitor Toxicity
- Cough
- Angioedema
- Teratogen (fetal renal malformations)
- Increased Creatinine (decreased GFR),
- HypERkalemia
- HypOtension
ACE Inhibitor C/I
- C1 esterase inhibitor deficiency → Angioedema
- C1EI def → too much complement activation on self cells
- Pregnancy → fetal renal malformations
- Bilateral renal artery stenosis → renal failure
ATII Receptor Blocker (ARB) Drugs
- Losartan
- candesartan
- valsartan
ARB Drug MOA
- Selectively block binding of ATII to AT1 receptor.
- Effects similar to ACE inhibitors, but ARBs do not increase bradykinin (no cough)
ARB Drug Clinical Use
- HTN
- HF
- proteinuria
- diabetic nephropathy w/intolerance to ACE inhibitors (e.g., cough, angioedema)
ARB Drug Toxicity
- HypERkalemia
- Decreased renal function
- HypOtension
- Teratogen
Aliskiren MOA
- Direct renin inhibitor
- Blocks conversion of angiotensinogen (liver) → ATI
- JG cells secrete renin in response to decreased renal blood pressure, increased sympathetic tone (β1), and/or decreased NaCl delivery to macula densa in DCT
Aliskiren Clinical Use
HTN
Aliskiren Toxicity
- HypERkalemia
- Decreased renal function
- HypOtension
Aliskiren C/I
diabetics taking ACE inhibitors or ARBs
Which drugs cause urine alkalinization?
Carbonic anhydrase inhibitors
Which drugs increase urine NaCl?
All diuretics except Acetazolamide
- Note: increasing naturiesis means serum NaCl may decrease
Which drugs increase urine potassium?
- Loop diuretics
- Thiazide diuretics
- Acetazolamide
Note: serum K+ may decrease as result
Which drugs decrease blood pH (cause acidemia)?
- Carbonic anhydrase inhibitors → decrease HCO3- reabsorption
-
K+ sparing: Aldosterone blockade → prevent K+/H+ secretion
- Hyperkalemia → K+ enters cells in exchange for H+ exiting cells (via K+/H+ exchg)
Which drugs increase blood pH (cause alkalemia)?
Loop diuretics and Thiazides:
- Volume contraction → increased ATII → increased Na+/H+ exchg in PCT → increased HCO3- reabsorption (“Contraction alkalosis”)
- K+ exits cells in exchg for H+ entering cells (via K+/H+ exchanger)
- Low K+ state → H+ rather than K+ exchg for Na+ in cortical collecting tubule → alkalosis, paradoxical aciduria
Which drugs increase excretion of Ca2+?
Loop diuretics
- decreased paracellular Ca2+ reabsorption → hypOcalcemia
Which drugs decrease excretion of Ca2+?
Thiazides:
- Enhanced Ca2+ reabsorption in DCT
Which drugs increase excretion of Mg2+?
Loop diuretics
- loss of lumen positive potential reduces ion reabsorption
Which drugs increase excretion of HCO3-?
Acetazolamide
Which drugs decrease excretion of HCO3-?
Loop diuretics
Which drugs increase excretion of phosphate?
Acetazolamide
- reduced reabsorption in acidosis